Cardiovascular event rate and death in high-risk secondary prevention patient cohort in Finland: A registry study

Iiro Toppila1, Liisa Ukkola-Vuoti1, Julia Perttilä2

  • 1Medaffcon Oy, Espoo, Finland.

Clinical Cardiology
|March 15, 2022
PubMed

Insights

Patients with atherosclerotic cardiovascular disease face high risks of recurrent events and death, especially within six months of their first event. Prompt secondary prevention is crucial to reduce these risks.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Atherosclerotic cardiovascular disease (CVD) affects numerous patients, placing them at significant risk for life-threatening cardiovascular events.
  • Real-world data is essential for understanding the long-term prognosis and management of patients post-cardiovascular event.

Purpose of the Study:

  • To evaluate the risk of recurrent cardiovascular events or death in a Finnish population following an initial atherosclerotic cardiovascular event.
  • To identify risk factors and assess the time to recurrence after a first cardiovascular event.

Main Methods:

  • Retrospective registry study design.
  • Inclusion of patients with an incident atherosclerotic CV event between 2012 and 2016.
  • Follow-up for recurrent CV events or death, with risk and time-to-recurrence analyses.

Main Results:

  • 48,405 patients were followed post-index CV event.
  • The event rate was 14.34 events per 100 patient-years.
  • At 5 years, 41.5% experienced death or recurrent CV event, with death being the most common (61.5%). Recurrent events and deaths accelerated within 6 months post-index event, often mirroring the initial event type (cardiac or cerebrovascular).

Conclusions:

  • High incidence of recurrent CV events and all-cause mortality observed post-first CV event.
  • The first 6 months post-index event represent a critical period for increased risk.
  • Accelerated event rates after each subsequent CV event underscore the need for immediate and intensified secondary prevention strategies to meet treatment goals.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
113
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
244
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
56
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
382
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.6K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
143